-
-
-
-
-
-
-
Halozyme Therapeutics (HALO) Confirms Proposal to Combine with Evotec (EVO) for €11.00 Per Share in an All-Cash Transaction
-
-
-
-
-
-
-
RenovoRx Appoints Leesa Gentry as Senior Vice President of Clinical Operations
-
-
-
-
-
-
-
Eaton Vance Closed-End Fund Data Now Available on Web Site
-
1,205,330 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

